CSI Entrepreneurship 50 Index (931643) is a unique cross-market index issued by China Securities Index Company, which covers both Ke and gem at the same time. In order to reflect the performance of listed companies representing emerging industries in Kechuang and gem, promote the development and innovation of indexed investment, and provide more abundant indexed investment tools for investors, China Securities Index Co., Ltd. released the CSI Entrepreneurship 50 Index (931643) on June 1, 2021. The base date of the index is December 31, 2019, with a base point of 1000 points.
There are a total of 50 stocks in the index, with a total market capitalization of more than 100 billion, including Ningde era, Mindray Medical, Ayre Ophthalmology, Zhifei Biology and other industry leaders. The number of companies with a total market capitalization of less than 100 billion and more than 100 billion is basically the same, while taking into account the stability of large market capitalization and the high elasticity of small market capitalization, the weight allocation of large and small market capitalization is more balanced, both offensive and defensive.
Compared with the Science and Technology Entrepreneurship 50 Index and the gem 50 Index, the Science and Technology Entrepreneurship 50 Index combines the advantages of the two major indexes, focusing on adding two industries, namely, health care, power and new energy equipment, while balancing the configuration of the electronics and computer industries. in addition, the proportion of media and Internet has been relatively reduced. The index mainly focuses on health care (40.16%, of which 13.47% for medical services, 13.43% for pharmaceuticals, 13.26% for medical devices), electricity and new energy (19.61%), electronics (19.55%) and computers (7.26%), covering hot emerging industries in the two sectors. In comparison, the pure Kechuang 50 index accounts for a very high proportion in the electronics and computer industries, and the pure gem 50 index accounts for a relatively high proportion in the health care, power and new energy equipment industries.
The growth of the index is predictable and the valuation is relatively reasonable. The index expects net profit to grow by about 43% in 2021, about 34% in 2022, and is expected to maintain a relatively high growth rate in the next two years. The current PE (TTM) of the index is about 81x. In terms of the valuation-growth regression line, the current valuation of the index is relatively reasonable.
China Merchants China Securities Division Entrepreneurship 50ETF (subscription code 588303, transaction code: 588300, on-site abbreviation:
Mass entrepreneurship and innovation ETF) the main investment goal is to closely track the CSI Venture 50 Index, and to minimize tracking deviation and tracking error. China Merchants Fund Management Co., Ltd. has rich experience in ETF management, including China Merchants China Securities Science Entrepreneurship 50ETF, there are 14 stock ETF and 8 linked funds (including An and C shares). The product line covers many investment directions and provides rich instrumental products for investors.
Risk hint
1. The simulated return test does not represent the real performance and does not guarantee the future income.
two。 Drastic changes have taken place in the macro environment.
